Menu

Filtros : "Archangelo, Leticia Fröhlich" "2022" Limpar

Filtros

Refine with date range

  • 1

1 - 2 (2 records)

  • Parte de monografia/livro

    Alternative splicing of pre-messenger RNA (2022)

    Arfelli, Vanessa Cristina; Archangelo, Leticia Fröhlich

    Source: Transcriptomics in health and disease. Unidade: FMRP

    Subjects: GENES, SEQUENCIAMENTO GENÉTICO, PROTEÔMICA, EXPRESSÃO GÊNICA, NEOPLASIAS

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      ARFELLI, Vanessa Cristina e ARCHANGELO, Leticia Fröhlich. Alternative splicing of pre-messenger RNA. Transcriptomics in health and disease. Tradução . Cham: Springer, 2022. . Disponível em: https://doi.org/10.1007/978-3-030-87821-4_2. Acesso em: 04 nov. 2024.

    • APA

      Arfelli, V. C., & Archangelo, L. F. (2022). Alternative splicing of pre-messenger RNA. In Transcriptomics in health and disease. Cham: Springer. doi:10.1007/978-3-030-87821-4_2

    • NLM

      Arfelli VC, Archangelo LF. Alternative splicing of pre-messenger RNA [Internet]. In: Transcriptomics in health and disease. Cham: Springer; 2022. [citado 2024 nov. 04 ] Available from: https://doi.org/10.1007/978-3-030-87821-4_2

    • Vancouver

      Arfelli VC, Archangelo LF. Alternative splicing of pre-messenger RNA [Internet]. In: Transcriptomics in health and disease. Cham: Springer; 2022. [citado 2024 nov. 04 ] Available from: https://doi.org/10.1007/978-3-030-87821-4_2

  • Artigo de periodico

    PIMREG expression level predicts glioblastoma patient survival and affects temozolomide resistance and DNA damage response (2022)

    Serafim, Rodolfo Bortolozo; Cardoso, Cibele; Arfelli, Vanessa Cristina; Valente, Valeria; Archangelo, Leticia Fröhlich

    Source: Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. Unidade: FMRP

    Subjects: ANTINEOPLÁSICOS, LINHAGEM CELULAR, DANO AO DNA, GLIOMA, FARMACOTERAPIA

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      SERAFIM, Rodolfo Bortolozo et al. PIMREG expression level predicts glioblastoma patient survival and affects temozolomide resistance and DNA damage response. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, v. 1868, p. 166382, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.bbadis.2022.166382. Acesso em: 04 nov. 2024.

    • APA

      Serafim, R. B., Cardoso, C., Arfelli, V. C., Valente, V., & Archangelo, L. F. (2022). PIMREG expression level predicts glioblastoma patient survival and affects temozolomide resistance and DNA damage response. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1868, 166382. doi:10.1016/j.bbadis.2022.166382

    • NLM

      Serafim RB, Cardoso C, Arfelli VC, Valente V, Archangelo LF. PIMREG expression level predicts glioblastoma patient survival and affects temozolomide resistance and DNA damage response [Internet]. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2022 ; 1868 166382.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1016/j.bbadis.2022.166382

    • Vancouver

      Serafim RB, Cardoso C, Arfelli VC, Valente V, Archangelo LF. PIMREG expression level predicts glioblastoma patient survival and affects temozolomide resistance and DNA damage response [Internet]. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2022 ; 1868 166382.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1016/j.bbadis.2022.166382
  • 1

1 - 2 (2 records)

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024